Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer. Tomudex Colorectal Cancer Study Group.
暂无分享,去创建一个
D. Kerr | E. Van Cutsem | D. Cunningham | K. Possinger | G. Cocconi | G. van Hazel | B. Gustavsson | E. François | E. V. Cutsem | S. M. Hietschold | G. V. Hazel | G. V. van Hazel | Kurt Possinger | David Cunningham | D. J. Kerr | Bengt Gustavsson
[1] M. Summerhayes,et al. Reduced pharmacy resource utilization associated with raltitrexed treatment of advanced colorectal cancer , 1997 .
[2] S. Barni,et al. High- versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: A ‘GISCAD’ phase III study , 1997 .
[3] M. Yin,et al. Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] D. Kerr,et al. Final results of a randomised trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. "Tomudex" Colorectal Cancer Study Group. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] S. Clarke,et al. Phase I trial of ZD1694, a new folate-based thymidylate synthase inhibitor, in patients with solid tumors. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] R. Sanderman. Measuring the quality of life of cancer patients with the Rotterdam Symptom Checklist (RSCL): a manual , 1996 .
[7] D. Cunningham,et al. Cost of treating advanced colorectal cancer: a retrospective comparison of treatment regimens. , 1996, European journal of cancer.
[8] F. Sinicrope,et al. Role of adjuvant therapy in surgically resected colorectal carcinoma. , 1995, Gastroenterology.
[9] L. Påhlman,et al. Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.
[10] W. Scheithauer,et al. Randomized comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin, and cisplatin therapy in patients with advanced colorectal cancer , 1994, Cancer.
[11] Colorectal carcinoma: current problems and future perspectives. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] H. Wieand,et al. Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] W. Scheithauer,et al. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. , 1993, BMJ.
[14] C. Boni,et al. Fluorouracil-alone versus high-dose folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research (GOIRC). , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.
[15] H. Wieand,et al. Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] S. Barni,et al. Folinic acid + 5-fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase III study of 'GISCAD' (Italian Group for the Study of Digestive Tract Cancer). , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.
[17] J. Laurie,et al. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] J. Hannigan,et al. Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] J. Fourtillan,et al. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] S. Holm. A Simple Sequentially Rejective Multiple Test Procedure , 1979 .
[21] R. Rubens,et al. Assessment of response to therapy in advanced breast cancer. , 1977, British Journal of Cancer.